ClearPoint Neuro Forecast, price target & analysts
ClearPoint Neuro Target price 2026 - Analyst rating & recommendation
ClearPoint Neuro Classifications & Recommendation
ClearPoint Neuro Price Target
| Target Price | $25.50 |
| Price | $14.61 |
| Potential |
74.54%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target ClearPoint Neuro 2027 .
The average ClearPoint Neuro target price is $25.50.
This is
74.54%
register free of charge
$31.50
115.61%
register free of charge
$22.22
52.09%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend ClearPoint Neuro to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ClearPoint Neuro stock has an average upside potential 2027 of
74.54%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 36.97 | 49.98 |
| 17.78% | 35.19% | |
| EBITDA Margin | -65.19% | -50.20% |
| 9.13% | 22.99% | |
| Net Margin | -69.08% | -82.37% |
| 14.68% | 19.23% |
4 Analysts have issued a sales forecast ClearPoint Neuro 2026 . The average ClearPoint Neuro sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an ClearPoint Neuro EBITDA forecast 2026. The average ClearPoint Neuro EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 ClearPoint Neuro Analysts have issued a net profit forecast 2026. The average ClearPoint Neuro net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.90 | -1.35 |
| 28.57% | 50.00% | |
| P/E | negative | |
| EV/Sales | 9.33 |
5 Analysts have issued a ClearPoint Neuro forecast for earnings per share. The average ClearPoint Neuro EPS is
This results in the following potential growth metrics and future valuations:
ClearPoint Neuro...
Current ClearPoint Neuro Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Mar 18 2026 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Mar 05 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Aug 01 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Jan 28 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | Jan 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Mar 18 2026 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Mar 05 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Aug 01 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Jan 28 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Jan 21 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
